
pmid: 29479805
Asperochramides A – D (1 – 4), a new natural product and three new indole diketopiperazine alkaloids, along with seven known analogs (5 – 11), were isolated from the ethyl acetate extract of Aspergillus ochraceus. Their structures were elucidated by extensive spectroscopic analyses, ECD calculation, and single‐crystal X‐ray diffraction analysis. Compounds 3 and 4 represent a rare group of indole diketopiperazine alkaloid with a 3‐hydroxyl‐2‐indolone moiety. The in vitro anti‐inflammatory effects of compounds 1 and 3 – 11 were investigated by using LPS‐stimulated murine macrophage RAW 264.7 cells. Compounds 1, 8, 10, and 11 showed potential anti‐inflammatory activities.
Aspergillus ochraceus, Lipopolysaccharides, Models, Molecular, Dose-Response Relationship, Drug, Macrophages, Anti-Inflammatory Agents, Molecular Conformation, Diketopiperazines, Crystallography, X-Ray, Mice, Structure-Activity Relationship, Alkaloids, RAW 264.7 Cells, Animals
Aspergillus ochraceus, Lipopolysaccharides, Models, Molecular, Dose-Response Relationship, Drug, Macrophages, Anti-Inflammatory Agents, Molecular Conformation, Diketopiperazines, Crystallography, X-Ray, Mice, Structure-Activity Relationship, Alkaloids, RAW 264.7 Cells, Animals
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 33 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
